TBG Diagnostics Limited announced the appointment of Mr. Willy M. Hsu as Chief Operating Officer of the Company. Mr. Hsu has ten years' experience as Marketing and Sales Manager with the Company's wholly owned subsidiary TBG Biotechnology Corp. focusing on the global sales and marketing of Human Leukocyte Antigen (HLA) genotyping. The company also advised the resignation of Mr. Eugene Cheng as Group Chief Operating Officer of the Company, Mr. Cheng will continue as a Non-Executive Director of the Company.